Skip to main content

Change in PDL Status for Linezolid Suspension Products Effective May 7, 2024

Last updated on

On May 7, 2024, the Texas Health and Human Services Commission (HHSC) removed the non-preferred status from generic linezolid suspension products on the preferred drug list (PDL).

The non-preferred status of the following drugs was removed:

National Drug Code (NDC)Drug Name
00054031950Linezolid 100 mg/5 ml suspension
31722086525Linezolid 100 mg/5 ml suspension

These changes will allow providers to prescribe the generic linezolid suspension products without requiring PDL prior authorization so that clients can continue accessing necessary medication.

Note: Pfizer, the manufacturer of brand name Zyvox suspension, confirmed that these two products are on long-term back order.

Email vdp-formulary@hhsc.state.tx.us with any comments or questions.